Trichomoniasis what causes it is a sexually transmitted infection caused by the single-celled protozoan parasite Trichomonas vaginalis. This organism infects the genital tract in both men and women, though symptoms are more common in people with vaginas.
The parasite thrives in warm, moist environments and is transmitted through direct genital-to-genital contact during sexual activity. It does not survive long outside the human body, so transmission requires close physical contact. The infection is not spread through casual contact, sharing toilets, or using public showers.
According to the Centers for Disease Control and Prevention (CDC), trichomoniasis is the most common curable sexually transmitted infection in the United States, affecting approximately 3.7 million people annually. Despite high prevalence, many cases go undiagnosed due to asymptomatic infection.
Trichomonas vaginalis attaches to epithelial cells lining the vagina, urethra, or prostate, where it multiplies and triggers inflammation. The parasite uses whip-like flagella to move and invade tissue, disrupting the protective mucosal barrier. This leads to increased cellular shedding and immune cell recruitment, causing visible signs of infection.
In women, the infection typically begins in the lower genital tract. The parasite invades the vaginal epithelium, leading to increased vascular permeability and fluid leakage. This results in the characteristic frothy, yellow-green vaginal discharge associated with trichomoniasis. Men may develop urethritis, but symptoms are less consistent and often absent.
A 2021 study published in Clinical Infectious Diseases found that infected individuals have higher levels of pro-inflammatory cytokines such as IL-6 and TNF-alpha in genital secretions, confirming the role of immune activation in symptom development.
Transmission occurs exclusively through unprotected sexual contact. The parasite cannot survive on surfaces or in water. A person can be infected with T. vaginalis without showing symptoms, making partner notification critical.
Risk factors include multiple sexual partners, inconsistent condom use, and a history of other STIs. Women who have had bacterial vaginosis or chlamydia are at higher risk of acquiring trichomoniasis. The CDC reports that Black women are disproportionately affected, with infection rates nearly four times higher than White women in national surveys.
| Transmission Risk Factor | Impact Level | Evidence Source |
|---|---|---|
| Unprotected sex | High | CDC 2023 STI Surveillance Report |
| Multiple partners | High | National Health and Nutrition Examination Survey (NHANES) |
| Condom non-use | High | Journal of Infectious Diseases, 2020 |
| History of other STIs | Moderate | Sexually Transmitted Infections, 2019 |
One non-obvious fact: Trichomonas vaginalis can persist in the male urethra for months without symptoms. A man may unknowingly transmit the parasite to a partner despite testing negative in standard urine tests. The CDC recommends treating both partners simultaneously to prevent reinfection.
Trichomoniasis is frequently mistaken for yeast infections or bacterial vaginosis due to overlapping symptoms. All three conditions can cause vaginal discharge, itching, and odor. However, the discharge in trichomoniasis is typically frothy and yellow-green, while yeast infections produce thick, white, cottage cheese-like discharge.
Many clinicians rely on wet mount microscopy, which detects motile parasites under a microscope. Sensitivity ranges from 50% to 70%, depending on technician skill. False negatives occur when parasite load is low or sample handling delays analysis.
More accurate methods include nucleic acid amplification tests (NAATs), which detect parasite DNA in vaginal swabs or urine samples. NAATs achieve 95% sensitivity and are recommended by the American College of Obstetricians and Gynecologists (ACOG) for routine screening in high-risk populations.
In 2022, a 28-year-old woman presented with persistent vaginal itching and malodorous discharge. She reported no recent sexual partners but had a history of recurrent yeast infections. Initial wet mount was negative. She was prescribed antifungal medication, but symptoms worsened.
A follow-up NAAT test revealed Trichomonas vaginalis DNA. She had contracted the infection from a previous partner who remained asymptomatic. Both she and her partner were treated with a single 2g dose of metronidazole. Symptoms resolved within five days.
This case illustrates that asymptomatic carriers can maintain transmission chains. The CDC estimates that 70% of infected individuals do not report symptoms, making routine screening essential in sexually active adults.
When diagnosed, trichomoniasis what causes it is treatable with oral antibiotics. Metronidazole or tinidazole are first-line agents. Treatment success rates exceed 90% when both partners complete the course and abstain from sex until cured.
Prevention relies on consistent condom use and regular STI screening. The CDC recommends annual testing for all sexually active women under 25 and those with new or multiple partners. Men should be screened if their partner tests positive.